Andrea Lancia

15PUBLICATIONS
25CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 19, 2026
Novel biomarkers driving treatment selection in metastatic castration-sensitive prostate cancer: fundamentals of personalized clinical decision making.

|Nov 27, 2025
Recent Advances in Androgen Receptor Pathway Inhibitors for Castration-Sensitive Prostate Cancer.

Andrea Lancia, Marco Oderda, Federico Camilli

|Aug 01, 2025
Ablative radiotherapy for polymetastatic disease: a new kid on the block.

Federico Camilli, Andrea Lancia, Sheetal R Kashid

|May 21, 2025
Current diagnostic and therapeutic options in de novo low-volume metastatic hormone-sensitive prostate cancer.

Gianluca Ingrosso, Andrea Lancia, Lilia Bardoscia

|May 07, 2025
Current Treatment Paradigms for Advanced Melanoma with Brain Metastases.

Elisabetta Bonzano, Stefania Barruscotti, Silvia Chiellino

|Mar 18, 2025
Hypofractionated radiotherapy in elderly patients (≥75 years) affected by localized prostate cancer: a multicenter retrospective analysis from the IPOPROMISE study.

Gianluca Ingrosso, Eleonora Festa, Saverio Caini

Pageof 3

Frequent Collaborators

6 joint publications

Gianluca Ingrosso

4 joint publications

Chandra Bortolotto

4 joint publications

Giulia Maria Stella

3 joint publications

Francesco Agustoni